cell cycle

(redirected from Cell-cycle)
Also found in: Dictionary, Medical.

Cell cycle

The succession of events that culminates in the asexual reproduction of a cell; also known as cell division cycle. In a typical cell cycle, the parent cell doubles its volume, mass, and complement of chromosomes, then sorts its doubled contents to opposite sides of the cell, and finally divides in half to yield two genetically identical offspring. Implicit in the term “cycle” is the idea that division brings the double-sized parent cell back to its original size and chromosome number, and ready to begin another cell cycle. This idea fits well with the behavior of many unicellular organisms, but for multicellular organisms the daughter cells may differ from their parent cell and from each other in terms of size, shape, and differentiation state.

The time required for completion of a eukaryotic cell cycle varies enormously from cell to cell. Embryonic cells that do not need to grow between divisions can complete a cell cycle in as little as 8 min, whereas cycling times of 10–24 h are typical of the most rapidly dividing somatic cells. Many somatic cells divide much less frequently; liver cells divide about once a year, and mature neurons never divide. Such cells may be thought of as temporarily or permanently withdrawing from the cell cycle.

Eukaryotic phases

The cell cycle is divided into two main parts: interphase and mitosis (see illustration). During interphase, the cell grows and replicates its chromosomes. Interphase accounts for all but an hour or two of a 24-h cell cycle, and is subdivided into three phases: gap phase 1 (G1), synthesis (S), and gap phase 2 (G2). Interphase is followed by mitosis (nuclear division) and cytokinesis (cell division). This relatively brief part of the cell cycle includes some of the most dramatic events in cell biology.

Phases of the eukaryotic cell cycleenlarge picture
Phases of the eukaryotic cell cycle

G1 phase

Gap phase 1 begins at the completion of mitosis and cytokinesis and lasts until the beginning of S phase. This phase is generally the longest of the four cell cycle phases and is quite variable in length. During this phase, the cell chooses either to replicate its deoxyribonucleic acid (DNA) or to exit the cell cycle and enter a quiescent state (the G0 phase).

S phase

Replication of the chromosomes is restricted to one specific portion of interphase, called S phase (DNA synthesis phase), which typically lasts about 6 h. In mammalian cells, the start of S phase—the actual initiation of DNA synthesis—takes place several hours after the cell has committed to carrying out DNA synthesis. During S phase, each chromosome replicates exactly once to form a pair of physically linked sister chromatids. In animal cells, a pair of centrioles is also duplicated during S phase. See Chromosome, Genetics

G2 phase

The portion of interphase that follows S phase is called gap phase 2. Some cells can exit the cell cycle from G2 phase, just as they can from G1 phase.

M phase

M phase includes the overlapping processes of mitosis and cytokinesis. Mitosis is divided into five stages: prophase, prometaphase, metaphase, anaphase, and telophase. Cytokinesis usually begins during anaphase and ends at a point after the completion of mitosis. At the end of cytokinesis, the parent cell has formed its two G1 phase progeny and the cell is ready to repeat the cycle. See Cytokinesis, Mitosis

Control of cell cycle

The network of proteins that regulate DNA synthesis (G1/S), mitotic entry (G1/M), and mitotic exit (the transition from mitotic metaphase to anaphase and then out of mitosis) appears to be well conserved throughout eukaryotic evolution. At the heart of these cell cycle transtions is the periodic activation and inactivation of cyclin-dependent protein kinases. In addition, in multicellular eukaryotes, pathways regulating entry into and exit from the cell cycle entrain these central cyclin-dependent kinases to extrinsic signals.

cell cycle

[′sel ‚sī·kəl]
(cell and molecular biology)
In eukaryotic cells, the cycle of events consisting of cell division, including mitosis and cytokinesis, and interphase.
References in periodicals archive ?
Taiwanin A arrests cell-cycle progression and induces nuclear condensation and DNA damage in MCF-7 cells
The DNA content and cell-cycle distribution in vehicle and taiwanin A-treated MCF-7 cells were analyzed using flow cytometry.
With the commencement of this trial, Sunesis continues to advance its portfolio of distinctive cell-cycle inhibitors with two product candidates now in clinical trials," said Dan Swisher, Chief Executive Officer of Sunesis.
SNS-032 is a novel aminothiazole small molecule cell-cycle modulator that targets CDK2, CDK7 and CDK9, thus halting the uncontrolled cell division characteristic of cancer.
In addition, the parties are to establish a new drug discovery alliance focused on the identification of novel inhibitors of other cell-cycle control enzymes.
Cytotoxic agents, including many cell-cycle inhibitors, remain the front-line standard of care in many cancers.
Mechanism of Action - such as Estrogen modulation, Cell-cycle inhibition, targeting of Bcl-2 or p53, Vegf/Vegfr or EGF/EGFr antagonist, or Tumor antigen etc.
SNS-595, a novel cell-cycle inhibitor in Phase I clinical trials, causes tumor regressions, cell cycle arrest, and apoptosis in murine models of colon cancer Abstract # 2277 -- The Phase I clinical compound SNS-595 acts during S-phase and causes sustained G2 arrest Abstract # 2293 -- The potent cytotoxic agent SNS-595 causes a rapid onset of apoptosis during the S-phase of the cell cycle Abstract # 2285 About SNS-595
Scientists studying links between genetic mutations and breast cancer have confirmed a protein's role in halting replication of abnormal DNA at cell-cycle checkpoints.
The abstract by Roy Pollock et al, "Cell shrinkage, cell-cycle arrest and anti-angiogenesis underlie the anti-tumor activity of the mTOR inhibitor, AP23573," is available on the AACR website (http://www.
Canji is a biotechnology company engaged in the development of innovative therapeutics based on tumor suppressor genes, cell-cycle regulators and growth modulators.
Since vinblastine is a cell-cycle specific drug, MPI 5017 may improve the safety and efficacy of the drug by localizing the effects of the drug to the site of administration in the tumor tissue and increasing its residence time within the tumor, while decreasing the incidence of side-effects associated with systemic delivery.